α-2,6-sialic acid/IgG anti-dsDNA ratios correlate with human lupus disease activity and possible mechanisms: A pilot study

Abstract

Objective

To study the association of α2,6-sialic acid (SIA) content in serum IgG anti-dsDNA with human systemic lupus erythematosus disease activity index (SLEDAI) and the effect of sialylated and desialylated (deSIA) IgG anti-dsDNA on lupus B cells.

Methods

Blood from lupus patients was collected to determine the ratio of SIA in isolated IgG anti-dsDNA over serum IgG anti-dsDNA (SIA/IgG anti-dsDNA) ratios, which were plotted against SLEDAI using a receiver-operating-characteristics curve. Lupus B cells were cultured in vitro with chimeric sialylated IgG anti-dsDNA and its deSIA form. Culture supernatants were assayed for anti-inflammatory IL-10 and SIA/IgG anti-dsDNA ratios, which were compared among different pre-treatment groups using t-tests.

Results

The area-under-the-curve (AUC) for anti-dsDNA levels against SLEDAI was 0.791 positively (95% confidence interval [C.I.]: 0.699–0.884) and SIA/IgG anti-dsDNA ratios against SLEDAI yielded an AUC of 0.705 inversely (95% C.I: 0.601–0.809): not significantly different. SIA/IgG anti-dsDNA ratios discriminated significantly between patients without and patients with proteinuria (p = .046). SIA/IgG anti-dsDNA ratios correlated significantly and positively with serum C3c and C4 levels. Pre-treatment with IgG anti-dsDNA and its immune complexes (dsDNA/IgG anti-dsDNA IC) induced higher IL-10 from lupus B cells than medium pre-treatment (most p < .01 from day 2 to day 5 culture). DeSIA IgG anti-dsDNA IC induced lower IL-10 (p < .05) and lower SIA/IgG anti-dsDNA ratios (p < .001) from lupus B cells than medium and dsDNA pre-treatment.

Conclusion

α2,6-SIA/IgG anti-dsDNA ratios inversely forecasted SLEDAI scores. Possible mechanisms may be due to the different effects of sialylated and deSIA IgG anti-dsDNA on lupus B cells in terms of IL-10 secretion and SIA/IgG anti-dsDNA ratios.

Keywords

Anti-dsDNA antibodies B cells IL-10 sialic acid systemic lupus erythematosus disease activity index

Get full access to this article

View all access options for this article.

References

Koffler

Agnello

Kimkel

. Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus. Am Journal Pathology 1974; 74: 109–124.

Tsao

Ebling

Roman

Panosian-Sahakian

Calame

Hahn

. Structural characteristics of the variable regions of immunoglobulin genes encoding a pathogenic autoantibody in murine lupus. J Clin Invest 1990; 85: 530–540.

Riboldi

Gerosa

Moroni

, et al.

Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?

Autoimmunity 2000; 38(1): 39–45.

Devey

Lee

Le Page

. Serial studies of the IgG subclass and functional affinity of DNA antibodies in systemic lupus erythematosus. J Autoimmun 1988; 1(5): 483–494.

Winkler

Henschel

Kalies

. Constant isotype pattern of anti-dsDNA antibodies in patients with systemic lupus erythematosus. Clin Experimental Immunology 1988; 72(3): 434–439.

Scallon

Tam

McCarthy

. Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. Mol Immunol 2007; 44: 1524–1534.

Kaneko

Nimmerjahn

Ravetch

. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 2006; 313: 670–673.

Jefferis

Lund

. Interaction sites on human IgG-Fc for FcγR: current models. Immunol Lett 2002; 82: 57–65.

Käsermann

Boerema

Rüegsegger

, et al. Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation. PLoS One 2012; 7: e37243.

10.

Wiedeman

Santer

Yan

. Contrasting mechanisms of interferon-α inhibition by intravenous immunoglobulin after induction by immune complexes versus Toll-like receptor agonists. Arthritis Rheumatism 2013; 65: 2713–2723.

11.

an de Geijn

Wuhrer

Selman

, et al. Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study. Arthritis Res Ther 2009; 11: R193.

12.

Stümer

Biermann

MHC

Knopf

, et al. Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy. Clin Exp Immunol 2017; 189: 372–382.

13.

Liou

L-B

Huang

C-C

. Reverse expression of α2,6-sialic acid ratios on IgG, IgM, and IgG/IgM autoantibodies correlates with mouse arthritis and rheumatoid arthritis disease activity. J Chin Med Assoc 2020; 83(12): 1079–1086.

14.

Vucˇkovic´

Kristic´

Gudelj

, et al. Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome. Arthritis Rheumatol 2015; 11: 2978–2989.

15.

Otani

Kuroki

Kikuchi

, et al. Sialylation determines the nephritogenicity of IgG3 cryoglobulins. J Am Soc Nephrol 2012; 23(11): 1869–1878.

16.

Fickentscher

Magorivska

Janko

, et al. The Pathogenicity of Anti-β2GP1-IgG autoantibodies depends on Fc Glycosylation. J Immunol Res 2015; 2015: 1–12.

17.

Lehoux

Groux-Degroote

Cazet

, et al. Transcriptional regulation of the human ST6GAL2 gene in cerebral cortex and neuronal cells. Glycoconjugate J 2010; 27: 99–114.

18.

Barb

Brady

Prestegard

. Branch-Specific Sialylation of IgG-Fc Glycans by ST6Gal-I. Biochemistry 2009; 48(41): 9705–9707. DOI: 10.1021/bi901430h

19.

Naraparaju

Yamamoto

. Roles of β-galactosidase of B lymphocytes and sialidase of T lymphocytes in inflammation-primed activation of macrophages. Immunol Lett 1994; 43: 143–148.

20.

Chen

Enioutina

Daynes

. The control of IL-4 gene expression in activated murine T lymphocytes: a novel role for neu-1 sialidase. J Immunology (Baltimore, Md. : 1950) 1997; 158: 3070–3080.

21.

Seyrantepe

Iannello

Liang

, et al. Regulation of phagocytosis in macrophages by neuraminidase 1. J Biol Chem 2010; 285: 206–215.

22.

Wang

Yamaguchi

Wada

, et al. A close association of the ganglioside-specific sialidase Neu3 with caveolin in membrane microdomains. J Biol Chem 2002; 277: 26252–26259.

23.

Jenner

Kerst

Handgretinger

. Increased α2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells. Exp Hematol 2006; 34: 1211–1217.

24.

Liou

L-b

Huang

C-c

. Sialyltransferase and neuraminidase levels/ratios and sialic acid levels in peripheral blood B cells correlate with measures of disease activity in patients with systemic lupus erythematosus and rheumatoid arthritis: a pilot study. PLoS ONE 2016; 11(3): e0151669. DOI: 10.1371/journal.pone.0151669

25.

Liou

. Different monocyte reaction patterns in newly diagnosed, untreated rheumatoid arthritis and lupus patients probably confer disparate C-reactive protein levels. Clin Experimental Rheumatology 2003; 21: 437–444.

26.

Sun

K-H

C-L

Tang

S-J

. Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1β, IL-6, IL-8, IL-10 and TNF-α from normal human mononuclear cells involving in the lupus pathogenesis. Immunology 2000; 99: 352–360.

27.

Kim

Lee

Kim

H-J

. Antibody-based enzyme-linked lectin assay (ABELLA) for the sialylated recombinant human erythropoietin present in culture supernatant. J Pharm Biomed Anal 2008; 48: 716–721.

28.

Griffin

Rothstein

. Human B1 cell frequency: isolation and analysis of human B1 cells. Front Immunol 2012; 3: 122.

29.

Eilat

Hochberg

Pumphrey

. Monoclonal antibodies to DNA and RNA from NZB/NZW F1 mice: antigenic specificities and NH2 terminal amino acid sequences. J Immunology (Baltimore, Md. : 1950) 1984; 133: 489–494.

30.

Kindt

Goldsby

Osborne

. Janis Kuby: Immunology. 6th ed. NY: Macmillan Higher Education, 2006.

31.

Martin

Smoląg

Björk

, et al. Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus. Arthritis Res Ther 2017; 19: 266.

32.

Kim

AHJ

Strand

Sen

, et al. Association of blood concentrations of complement split productiC3b and serum C3 with systemic lupus erythematosus disease activity. Arthritis Rheumatol 2019; 71(3): 420–430.

33.

Swaak

AJG

Hannema

Vogelaar

, et al. Determination of the half-life of C3 in patients and its relation to the presence of C3-breakdown products and/or circulating immune complexes. Rheumatol Int 1982; 2: 161–166.

34.

Teisner

Brandslund

Grunnet

. Acute complement activation during an anaphylactoid reaction to blood transfusion and the disappearance rate of C3c and C3d from the circulation. J Clinical Laboratory Immunology 1983; 12(2): 63–67.

35.

Chen

L-Z

. Molecular basis for complement recognition by integrin α X β 2. Proc Natl Acad Sci 2012; 109: 4586–4591.

36.

Yan

Větvička

Xia

. Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble β-glucan. Immunopharmacology 2000; 46: 39–54.

37.

van de Bovenkamp

Hafkenscheid

Rispens

. The emerging importance of IgG Fab glycosylation in immunity. J Immunol 2016; 196: 1435–1441.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.27 MB